azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor]
azilsartan medoxomil
RxCUI: 1235150
What the CMS Formulary Data Shows for azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor]
Per the CMS 2026 Part D formulary file, azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] (RxNorm concept RXCUI 1235150, generic name azilsartan medoxomil) appears on 93 distinct formulary files spanning 2,643 Medicare Part D plan offerings - 52.2% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 3.4.
Real-world access to azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 18.3% require step therapy. 53.8% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 17,111 Part D beneficiaries filled azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] in 2023, with total plan-and-beneficiary spending of $36,819,212 and an average per-beneficiary annual cost of $2,151.79. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] today.
Coverage Details
- Formularies covering
- 93
- Plans covering
- 2,643
- Coverage rate
- 52.2%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 18.3% of formularies
- Quantity limits
- 53.8% of formularies
2023 Medicare Spending
- Beneficiaries
- 17,111
- Total spending
- $36,819,212
- Avg per beneficiary
- $2,151.79
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| ElderServe MAP (HMO D-SNP) | ELDERSERVE HEALTH, INC. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | GROUP HEALTH COOPERATIVE OF EAU CLAIRE | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | LONGEVITY HEALTH PLAN OF NEW JERSEY INSURANCE COMP | T1 | No | $0 | NJ |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | UPPER PENINSULA HEALTH PLAN, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | CARESOURCE GEORGIA CO. | T1 | No | $0 | GA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP CARESOURCE | T1 | No | $0 | MI |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | No | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | No | $0 | MN |
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF FLORIDA, INC. | T1 | No | $4.80 | FL |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | HCSC INSURANCE SERVICES COMPANY | T1 | No | $4.80 | TX |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS INSURANCE COMPANY | T1 | No | $5.00 | OK |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF MICHIGAN, INC. | T1 | No | $8.80 | MI |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF ILLINOIS, INC. | T1 | No | $15.20 | IL |
| WellSense Added Value (HMO) | BOSTON MEDICAL CENTER HEALTH PLAN, INC. | T1 | No | $21.70 | NH |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF COLORADO, INC. | T1 | No | $35.20 | CO |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF NORTH CAROLINA, INC. | T1 | No | $36.20 | NC |
| Longevity Health Plan (PPO I-SNP) | LONGEVITY HEALTH PLAN OF NEW JERSEY INSURANCE COMP | T1 | No | $40.00 | NJ |
| ElderServe Star (HMO I-SNP) | ELDERSERVE HEALTH, INC. | T1 | No | $58.80 | NY |
| Longevity Health Plan (HMO I-SNP) | LONGEVITY HEALTH PLAN OF NEW YORK, INC. | T1 | No | $58.80 | NY |
| Leon MediExtra (HMO) | LEON HEALTH, INC. | T2 | No | $0 | FL |
| Leon MediDual (HMO D-SNP) | LEON HEALTH, INC. | T2 | No | $0 | FL |
| Leon MediMore (HMO) | LEON HEALTH, INC. | T2 | No | $0 | FL |
| Leon MediMax (HMO D-SNP) | LEON HEALTH, INC. | T2 | No | $0 | FL |
| Anthem I CareMore Medicare Advantage 2 (HMO-POS) | BLUE CROSS OF CALIFORNIA | T3 | No | $0 | CA |
| Anthem I CareMore Chronic Care (HMO-POS C-SNP) | BLUE CROSS OF CALIFORNIA | T3 | No | $0 | CA |
| Anthem I CareMore Home Care (HMO I-SNP) | BLUE CROSS OF CALIFORNIA | T3 | No | $0 | CA |
| Anthem I CareMore Chronic Care (HMO-POS C-SNP) | BLUE CROSS OF CALIFORNIA | T3 | No | $0 | CA |
| Anthem I CareMore Lung Care (HMO-POS C-SNP) | BLUE CROSS OF CALIFORNIA | T3 | No | $0 | CA |
| Anthem I CareMore Kidney Care (HMO-POS C-SNP) | BLUE CROSS OF CALIFORNIA | T3 | No | $0 | CA |
| Anthem I CareMore Lung Care (HMO-POS C-SNP) | BLUE CROSS OF CALIFORNIA | T3 | No | $0 | CA |
| Anthem I CareMore Kidney Care (HMO-POS C-SNP) | BLUE CROSS OF CALIFORNIA | T3 | No | $0 | CA |
| Wellpoint Lung Care (HMO-POS C-SNP) | WELLPOINT HEALTH PLANS, INC. | T3 | No | $0 | AZ |
| Wellpoint Chronic Care (HMO-POS C-SNP) | WELLPOINT HEALTH PLANS, INC. | T3 | No | $0 | AZ |
| Wellpoint Medicare Advantage 1 (HMO-POS) | WELLPOINT HEALTH PLANS, INC. | T3 | No | $0 | AZ |
| Wellpoint Premium Savings (HMO) | WELLPOINT HEALTH PLANS, INC. | T3 | No | $0 | AZ |
| Wellpoint I CareMore Home Care (HMO I-SNP) | WELLPOINT HEALTH PLANS, INC. | T3 | No | $0 | AZ |
| Wellpoint I CareMore Home Care (HMO I-SNP) | WELLPOINT HEALTH PLANS, INC. | T3 | No | $0 | AZ |
| Wellpoint Medicare Advantage 2 (HMO-POS) | WELLPOINT TEXAS, INC. | T3 | No | $0 | AZ |
| Wellpoint I CareMore Home Care 2 (HMO I-SNP) | WELLPOINT TEXAS, INC. | T3 | No | $0 | AZ |
| Wellpoint Lung Care 2 (HMO-POS C-SNP) | WELLPOINT TEXAS, INC. | T3 | No | $0 | AZ |
| Wellpoint Chronic Care 2 (HMO-POS C-SNP) | WELLPOINT TEXAS, INC. | T3 | No | $0 | AZ |
| Wellpoint I CareMore Kidney Care (HMO-POS C-SNP) | WELLPOINT TEXAS, INC. | T3 | No | $0 | AZ |
| Anthem Chronic Care (HMO-POS C-SNP) | HealthKeepers, Inc. | T3 | No | $0 | VA |
| Anthem I CareMore Medicare Advantage (HMO-POS) | BLUE CROSS OF CALIFORNIA PARTNERSHIP PLAN, INC. | T3 | No | $0 | CA |
| Anthem I CareMore Premium Savings (HMO-POS) | BLUE CROSS OF CALIFORNIA PARTNERSHIP PLAN, INC. | T3 | No | $0 | CA |
| Anthem I CareMore Medicare Advantage (HMO-POS) | BLUE CROSS OF CALIFORNIA PARTNERSHIP PLAN, INC. | T3 | No | $0 | CA |
Frequently Asked Questions
Is azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] covered by Medicare Part D?
Yes, azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] is covered by 2,643 Medicare Part D plans (52.2% of all Part D formularies).
What tier is azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] on Medicare Part D plans?
azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] averages Tier 3.4 across Part D plans, ranging from Tier 1 to Tier 6.
Does azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] require prior authorization?
0% of Part D formularies require prior authorization for azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor]. Step therapy: 18.3%. Quantity limits: 53.8%.
How much does Medicare spend on azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor]?
In 2023, total Medicare Part D spending on azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] was $36,819,212, covering 17,111 beneficiaries. The average spend per beneficiary was $2,151.79.
Read our methodology - how this data is sourced, computed, and verified.